CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

GSK

Saddam Huq, Director, Cold Chain and Logistics

Cold Chain Shipments Using Temperature Controlled Reefers via Sea Freight

Saddam Huq

Saddam Huq

Pharmaceutical Freight Integrator

Introduction


The demand for temperature-controlled pharmaceutical shipments is increasing and sea freight has emerged as a viable transportation mode for cold chain logistics. When handling pharmaceuticals and specialty medicines that require strict temperature control between 2°C and 8°C, reefer containers provide a cost-effective, environmentally friendly and robust solution.


Advantages of Reefer Containers in Cold Chain Logistics


Using reefer containers for sea freight offers multiple benefits, including cost savings and reduced carbon emissions compared to air freight. In addition to this, it provides a reliable method of maintaining temperature control throughout the transportation process. However, the complexity of sea freight logistics requires coordination among multiple stakeholders, including warehouses, road transport carriers, port authorities, reefer maintenance teams and vessel crews. The end-to-end transport of a reefer container via sea-freight can be visualized below:


Key Considerations for Cold Chain Shipments via Sea Freight


1. Qualification of Temperature-Controlled Reefers


To ensure reefer containers maintain the required temperature range across various climatic conditions, a thorough qualification process is necessary within the pharma environment. This includes:


Thermal Mapping: Assessing reefer performance in different climatic zones using temperature sensors within the cargo load to assess risk areas and temperature homogeneity within the reefer container. Equipment Types: Common reefer brands that needs to be within the qualification scope include Carrier (Primeline/ Thinline), Thermo King, Daikin and Star Cool that form majority of the equipment available in the fleet.


Qualification Testing: Conducting yard or simulated chamber tests to evaluate stress factors and power failure scenarios, determining how long the reefer can maintain its internal temperature without an external power source.


2. Continuous Power Supply & Temperature Maintenance


Temperature-controlled reefers need a constant power supply to regulate internal temperatures as per the set-point. During sea-freight, they are unplugged and reconnected at various journey nodes (e.g., road, port, vessel). This unplugged period is critical, as reefers struggle to maintain temperatures for long, especially in extreme climates. In winter, temperatures may drop below -15°C, and in summer, they can exceed 45°C. Without power, reefers have limited ability to maintain a strict 2°C to 8°C range. Ensuring continuous power supply or mitigation strategies is crucial to preserving cargo integrity in challenging environmental conditions.


During transportation, the reefer must be:


• Plugged into a power source at sea-ports (i.e. reefer dock) and on sea vessels


• Connected to a Generator Set (Gen-Set) during road (on land) transportation.


3. Sea-Port Assessments and Handling Risks


Pharmaceutical companies must assess sea-ports to mitigate risks associated with reefer container handling. Critical evaluations include:


• Customs clearance time and inspection if cargo needs to be opened


• Potential demurrage risks and associated cost if additional clearance time is required at ports or bonded warehouses.


• Insurance threshold value could be exceeded based on the commercial value of the cargo


• Cold chain risk assessments for bonded warehouse storage options.


• Commitments from sea carriers and port authorities to ensure timely re-connection to power sources at ports and on vessels. The maximum time reefers would be un-plugged must be evaluated based on the feedback/assessment and understand the potential risk. Additional thermal protection measures could be included such as applying thermal blankets to delay potential temperature excursions during plug-off period.


4. Reefer Pre-Requisites & Maintenance


The age and condition of reefer containers are crucial for pharmaceutical shipments. Strict guidelines include:


Age Restriction: Some pharmaceutical companies enforce limits on reefer container age.


Pre-Trip Inspections (PTI): Reefer maintenance teams must conduct full pre-trip inspections before each shipment, ensuring:


• Reefer structural integrity .Functionality of electronic and mechanical components


• Cleanliness and dryness of the container interior


• Routine Reefer Servicing: Regular servicing of cooling systems, insulation and air circulation mechanisms to ensure reliability


Monitoring temperature deviations is critical for ensuring compliance with Good Distribution Practices, requiring real-time tracking, routine checks and emergency response plans.

Reefer Calibration and Service: Reefers are typically equipped with four temperature sensors to monitor supply and return air temperatures. Reefer temperature control typically includes:


• Automatic probe diagnostics to detect sensor discrepancies.


• Periodic sensor checks and replacements if readings deviate from acceptable ranges.


• Use of backup sensors to mitigate risks associated with sensor malfunctions.


5. Preparation of Reefers for Pharmaceutical Shipments


To ensure cargo integrity, pharmaceutical shipments in reefer containers must follow specific preparation processes:


• Use of air-bags and cord-straps to prevent pallet movement and product damage. •Floor mats to facilitate proper air circulation around the container.


• Temperature settings with a set-point of +5°C for optimal stability for +2°C to +8°C shipments.


• De-humidification control set to "OFF" to prevent temperature fluctuations.


• Placement of independent temperature data loggers at critical points (e.g. front and back of the container) to monitor temperature conditions.


6. Real-Time Temperature Monitoring & Risk Mitigation


Monitoring temperature deviations is critical for ensuring compliance with Good Distribution Practices (GDP). Key monitoring practices include:


• Real-time temperature tracking devices in the cargo load that provide alerts if temperature deviations occur.


• Routine checks by vessel crew operators, usually conducted twice daily during sea voyage.


• Live monitoring capabilities offered by some sea carriers, allowing operators to detect temperature anomalies and perform minor repairs on board.


• Port-side monitoring at regular intervals to verify reefer temperature compliance.


• Emergency response plans to address power failures or reefer malfunctions in transit.


7. Regulatory Compliance & Documentation


Pharmaceutical shipments via sea freight must adhere to stringent regulatory guidelines, including:


• Good Distribution Practices (GDP) ensuring temperature integrity is maintained.


• Customs and import/export regulations that vary by country.


• Documented temperature records to provide traceability and ensure compliance.


• Standard operating procedures (SOPs) for handling, monitoring, and responding to temperature excursions.


• Audit of Logistics Service Providers


• Service Level Agreements and/or Quality Agreements with Logistics Service Provider to ensure all expectations and requirements are clearly defined


8. Sustainability Benefits of Sea Freight Cold Chain


Using sea freight for pharmaceutical cold chain shipments presents significant environmental benefits:


• Reduced Carbon Footprint: Sea freight generates significantly lower CO₂ emissions than air freight.


• Energy-Efficient Reefer Technologies: Advancements in reefer insulation and cooling systems help reduce energy consumption.


• Sustainable Packaging Solutions: Use of sea-freight will dictate lower consumption of cold chain packaging materials that are used for air-freight, thus reducing environmental impact.


Conclusion


Sea freight with temperature-controlled reefer containers offers a cost-effective, sustainable option for pharmaceutical shipments. Meticulous planning, strict qualification, continuous power, risk assessments, and real-time monitoring ensure product integrity, optimizing costs and reducing environmental impact while ensuring safe transport of temperaturesensitive products.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.

Editorial Lens

Cold chain logistics has become a strategic determinant of pharmaceutical reliability as biologics, specialty therapies and global distribution demands continue to intensify. This perspective illustrates why resilient temperature-controlled freight operations now sit at the center of risk management, product integrity and patient access.

The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://supplements-europe.lifesciencesreview.com/leadership-perspective/cold-chain-shipments-using-temperature-controlled-reefers-via-sea-freight-nwid-3065.html